Dalbavancin Tested against Staphylococcus aureus Isolates with Decreased Susceptibility to Glycopeptides and/or Lipopeptides from European Hospitals (2012-2016)
Dalbavancin Tested against Staphylococcus aureus Isolates with Decreased Susceptibility to Glycopeptides and/or Lipopeptides from European Hospitals (2012-2016). Lead author: RE Mendes, presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, April 22-26, Vienna Austria
# P0138